NZ759963A - Sleep disorder compositions and treatments thereof - Google Patents
Sleep disorder compositions and treatments thereofInfo
- Publication number
- NZ759963A NZ759963A NZ759963A NZ75996318A NZ759963A NZ 759963 A NZ759963 A NZ 759963A NZ 759963 A NZ759963 A NZ 759963A NZ 75996318 A NZ75996318 A NZ 75996318A NZ 759963 A NZ759963 A NZ 759963A
- Authority
- NZ
- New Zealand
- Prior art keywords
- weight
- extract
- cannabis
- amount
- sleep
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017902338A AU2017902338A0 (en) | 2017-06-19 | Sleep Disorder Composition and Treatment Thereof | |
| AU2017904818A AU2017904818A0 (en) | 2017-11-29 | Sleep Disorder Compositions and Treatments Thereof | |
| PCT/AU2018/050604 WO2018232448A1 (en) | 2017-06-19 | 2018-06-19 | COMPOSITION AGAINST SLEEP APNEA AND RELATED TREATMENTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ759963A true NZ759963A (en) | 2022-07-01 |
Family
ID=62947713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ759963A NZ759963A (en) | 2017-06-19 | 2018-06-19 | Sleep disorder compositions and treatments thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20210145910A1 (enExample) |
| EP (1) | EP3641754A4 (enExample) |
| JP (1) | JP2020524151A (enExample) |
| KR (1) | KR20200104278A (enExample) |
| CN (1) | CN110944632A (enExample) |
| AU (2) | AU2018100837B4 (enExample) |
| BR (1) | BR112019026877A2 (enExample) |
| CA (1) | CA3065563C (enExample) |
| CL (1) | CL2019003635A1 (enExample) |
| CO (1) | CO2019013887A2 (enExample) |
| IL (1) | IL271503A (enExample) |
| MX (1) | MX387442B (enExample) |
| NZ (1) | NZ759963A (enExample) |
| PE (1) | PE20201163A1 (enExample) |
| SG (1) | SG11201912380XA (enExample) |
| WO (1) | WO2018232448A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3031810A1 (en) | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| US11040932B2 (en) | 2018-10-10 | 2021-06-22 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| CA3027876A1 (en) * | 2018-12-18 | 2020-06-18 | Tetra Bio-Pharma | Cannabis compositions and methods |
| NL2022616B1 (en) | 2019-02-21 | 2020-09-18 | Patrick Alexander Unger | Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia |
| US10946054B1 (en) * | 2019-10-08 | 2021-03-16 | Jenny's Rose, LLC | Therapeutic cannabis extracts |
| WO2021178579A1 (en) * | 2020-03-03 | 2021-09-10 | Alte Verde Llc | Cannabis treatment of insomnia, pain, and skin conditions |
| EP4117641A1 (en) * | 2020-03-09 | 2023-01-18 | This Works Products Limited | Compositions comprising functional fragrances and cannabis-derived compounds |
| CN112057894A (zh) * | 2020-09-08 | 2020-12-11 | 云南工麻生物科技有限公司 | 一种提取大麻二酚的方法 |
| CA3200651A1 (en) * | 2020-12-04 | 2022-06-09 | Joel Ernest George HARDY | Antiinflammatory compositions comprising cannabidiol, delta-9- tetrahydrocannabinol and linalool |
| CN113143995A (zh) * | 2021-01-21 | 2021-07-23 | 龙麻(上海)医药研发有限责任公司 | 一种大麻提取物舌下片及其制备工艺和应用 |
| CN112999218A (zh) * | 2021-01-21 | 2021-06-22 | 龙麻(上海)医药研发有限责任公司 | 一种具有镇静助眠功效的组合物及用途 |
| MX2023008876A (es) * | 2021-01-28 | 2023-09-12 | Zynerba Pharmaceuticals Inc | Tratamiento de la apnea del sueño con cannabidiol (cbd). |
| CN112791151B (zh) * | 2021-02-20 | 2022-04-01 | 山东新稀宝股份有限公司 | 一种具有改善睡眠功能的组合物及应用 |
| DK181329B1 (en) | 2021-05-04 | 2023-08-16 | Cs Medica As | Nasal sleep spray composition, method for its provision, and receptacle and kit comprising said composition |
| US20220401407A1 (en) * | 2021-06-09 | 2022-12-22 | Demetrix, Inc. | Regulation of the sleep/wake cycle using cannabinoid compounds |
| CA3238591A1 (en) * | 2022-01-27 | 2023-08-03 | Paul MUCHOWSKI | A cannabidiol (cbd) and terpene formulation that increases restorative sleep in humans |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6949582B1 (en) * | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
| DE10051427C1 (de) * | 2000-10-17 | 2002-06-13 | Adam Mueller | Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte |
| JP4657716B2 (ja) | 2002-08-14 | 2011-03-23 | ジーダブリュー・ファーマ・リミテッド | 植物材料からの薬学的に活性な成分の抽出の改良 |
| GB2418612A (en) | 2004-10-01 | 2006-04-05 | Gw Pharma Ltd | Inhibition of tumour cell migration with cannabinoids |
| GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| GB201117956D0 (en) | 2011-10-18 | 2011-11-30 | Otsuka Pharma Co Ltd | Phytocannabinoids for use in the treatment of breast cancer |
| EP2844243B8 (en) | 2012-05-03 | 2019-12-18 | Echo Pharmaceuticals B.V. | Method for preparing a cannabis plant isolate comprising delta-9-tetrahydrocannabinol |
| CA2895805A1 (en) | 2012-12-18 | 2014-06-26 | Kotzker Consulting Llc | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
| US9763991B2 (en) * | 2013-06-13 | 2017-09-19 | Cannabis Science International Holding B.V. | Composition for the treatment of neurobehavioral disorders |
| CN103355391A (zh) * | 2013-08-13 | 2013-10-23 | 汕头大学医学院第一附属医院 | 一种五味健脑益智饼及其制备方法 |
| US10265292B2 (en) | 2013-09-18 | 2019-04-23 | The Werc Shop, LLC | Terpene-based compositions, processes methodologies |
| DK3062606T3 (da) | 2013-10-29 | 2019-06-24 | Biotech Inst Llc | Forædling, fremstilling, forarbejdning og anvendelse af speciel cannabis |
| KR20160094950A (ko) | 2013-10-31 | 2016-08-10 | 풀 스펙트럼 래버러토리즈, 리미티드 | 테르펜 및 칸나비노이드 제제 |
| CN105010577A (zh) | 2014-04-17 | 2015-11-04 | 天津市麦地那食品贸易有限公司 | 一种火麻、橄榄、葡萄籽、葵花籽调和油 |
| CA2952934A1 (en) | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
| AU2015308546A1 (en) | 2014-08-25 | 2017-04-13 | Clk Consult V/ Carsten Leonhard Knudsen | Device with compositions for delivery to the lungs, the oral mucosa and the brain |
| US9730911B2 (en) * | 2014-10-21 | 2017-08-15 | United Cannabis Corp. | Cannabis extracts and methods of preparing and using same |
| HK1244710A1 (zh) | 2014-12-12 | 2018-08-17 | Ojai Energetics Pbc | 微胶囊化大麻素组合物 |
| MX386351B (es) * | 2015-01-31 | 2025-03-18 | Constance Therapeutics Inc | Métodos para la preparación de extractos y composiciones de aceite de cannabis. |
| MX2017010872A (es) | 2015-02-27 | 2018-05-07 | Ebbu Llc | Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales. |
| CA2986268C (en) * | 2015-05-28 | 2024-01-02 | Insys Development Company, Inc. | Stable cannabinoid formulations |
| IL246790A0 (en) * | 2016-07-14 | 2016-09-29 | Friedman Doron | Self-dissolving compounds of cannabinoids |
| MX386086B (es) | 2016-08-03 | 2025-03-18 | Zelda Therapeutics Operations Pty Ltd | Composicion de cannabis |
| CA3031810A1 (en) | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| US9649349B1 (en) * | 2017-01-19 | 2017-05-16 | Metamorphic Alchemy & Distillations, Inc. | System and method for producing a terpene-enhanced cannibinoid concentrate |
| US20200179269A1 (en) * | 2017-03-20 | 2020-06-11 | Kanabo Research Ltd. | Vaporizable compositions comprising cannabinol |
| US20180352848A1 (en) * | 2017-06-07 | 2018-12-13 | NC3 Systems | Smokable cannabis-based product with reduced psychoactive effects |
| EP3681525A4 (en) | 2017-09-15 | 2020-09-02 | Zelda Therapeutics Operations Pty Ltd | COMPOSITION AND METHOD OF PROCESSING AUTISM |
| EP3745884A1 (en) * | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| AU2018100924A4 (en) | 2018-07-03 | 2018-08-09 | Zelira Therapeutics Operations Pty Ltd | Composition and method for treating pain |
| BR112022025302A2 (pt) | 2020-06-12 | 2023-02-28 | Zelira Therapeutics Operations Pty Ltd | Composição e método para tratamento da dor crônica |
| WO2022094671A1 (en) | 2020-11-06 | 2022-05-12 | Zelira Therapeutics Operations Pty Ltd | Cannabinoid encapsulation technology |
-
2018
- 2018-06-19 WO PCT/AU2018/050604 patent/WO2018232448A1/en not_active Ceased
- 2018-06-19 JP JP2019569956A patent/JP2020524151A/ja not_active Ceased
- 2018-06-19 NZ NZ759963A patent/NZ759963A/en unknown
- 2018-06-19 AU AU2018100837A patent/AU2018100837B4/en active Active
- 2018-06-19 CN CN201880040782.8A patent/CN110944632A/zh active Pending
- 2018-06-19 PE PE2019002553A patent/PE20201163A1/es unknown
- 2018-06-19 EP EP18821181.7A patent/EP3641754A4/en active Pending
- 2018-06-19 BR BR112019026877-4A patent/BR112019026877A2/pt not_active Application Discontinuation
- 2018-06-19 SG SG11201912380XA patent/SG11201912380XA/en unknown
- 2018-06-19 US US16/623,525 patent/US20210145910A1/en not_active Abandoned
- 2018-06-19 KR KR1020207001714A patent/KR20200104278A/ko not_active Ceased
- 2018-06-19 AU AU2018286647A patent/AU2018286647B2/en active Active
- 2018-06-19 MX MX2019015315A patent/MX387442B/es unknown
- 2018-06-19 CA CA3065563A patent/CA3065563C/en active Active
-
2019
- 2019-12-10 CO CONC2019/0013887A patent/CO2019013887A2/es unknown
- 2019-12-12 CL CL2019003635A patent/CL2019003635A1/es unknown
- 2019-12-17 IL IL271503A patent/IL271503A/en unknown
-
2023
- 2023-02-21 US US18/171,983 patent/US12239680B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018100837B4 (en) | 2019-02-21 |
| CL2019003635A1 (es) | 2020-06-19 |
| EP3641754A1 (en) | 2020-04-29 |
| KR20200104278A (ko) | 2020-09-03 |
| SG11201912380XA (en) | 2020-01-30 |
| MX2019015315A (es) | 2020-02-17 |
| AU2018286647B2 (en) | 2024-03-28 |
| AU2018100837A4 (en) | 2018-07-26 |
| CN110944632A (zh) | 2020-03-31 |
| US20210145910A1 (en) | 2021-05-20 |
| WO2018232448A1 (en) | 2018-12-27 |
| IL271503A (en) | 2020-02-27 |
| EP3641754A4 (en) | 2021-03-10 |
| JP2020524151A (ja) | 2020-08-13 |
| CA3065563A1 (en) | 2018-12-27 |
| CA3065563C (en) | 2023-06-13 |
| US20230270808A1 (en) | 2023-08-31 |
| US12239680B2 (en) | 2025-03-04 |
| MX387442B (es) | 2025-03-18 |
| BR112019026877A2 (pt) | 2020-06-30 |
| CO2019013887A2 (es) | 2020-04-01 |
| AU2018286647A1 (en) | 2020-01-16 |
| PE20201163A1 (es) | 2020-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12239680B2 (en) | Sleep disorder compositions and treatments thereof | |
| US12239628B2 (en) | Cannabis composition | |
| KR20210071939A (ko) | 통증을 치료하기 위한 조성물 및 방법 | |
| WO2019051560A1 (en) | COMPOSITION AND METHOD OF TREATMENT OF AUTISM | |
| CA3104739A1 (en) | Cannabinoid composition and method for treating ptsd and/or anxiety | |
| NZ789786A (en) | Sleep Disorder Compositions and Treatments Thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 JUN 2024 BY GRIFFITH HACK Effective date: 20230606 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 19 JUN 2025 BY GRIFFITH HACK Effective date: 20240522 |